Researchers discover potential genetic target for heart disease

Nov 17, 2010

Researchers at the University of Cincinnati (UC) have found a potential genetic target for heart disease, which could lead to therapies to prevent the development of the nation's No. 1 killer in its initial stages.

These findings will be presented for the first time at the American Heart Association's (AHA) Scientific Sessions in Chicago Nov. 17.

The study, led by WenFeng Cai, PhD, a postdoctoral fellow under the direction of Litsa Kranias, PhD, AHA distinguished scientist and Hanna Chair in Cardiology in the department of pharmacology and cell biophysics, shows that a micro-RNA, known as miR765, which regulates gene expressions, can down-regulate the expression of protein phosphatase 1 inhibitor-1 (I-1) and reduce the contractility of cells that make up cardiac muscle.

"Previous studies have shown that the reduction in I-1 expression may play a role in the of heart disease," Cai says. "However, the underlying contributing to this down-regulation is unknown.

"We wanted to see if miR765 would serve as a candidate to regulate this protein expression and affect the contractility of the cardiac muscle cells."

Using a agent—or virus—researchers moved either miR-765 or a control agent into ventricular cells of animal models.

Data showed that the expression of I-1 messenger was decreased by 20 percent in the miR765 cells of these models when compared with the control models.

"Under resting conditions, the contractile parameters were decreased in miR765-treated animal models," Cai says. "Although beta adrenergic agonist, used to speed up the pumping action of the heart, had a positive effect, the contractile function remained suppressed in the miR765 group."

Cai adds that analysis showed both phosphorylations of phospholamban and ryanodine receptor, the proteins that regulate calcium uptake and calcium release, were significantly reduced in the miR765 group both in the presence and in the absence of beta adrenergic agonist.

"These findings show that miR765 can down-regulate the expression and reduce contractility of heart cells by decreasing or deactivating a number of proteins that help the heart function at full capacity," Cai says. "This leads us to believe that miR765 may play a role in the development of heart failure.

"Hopefully, these findings will lead to future studies, helping researchers and clinicians develop a therapeutic target to stop where it first starts: in the genes."

Explore further: Smartphone experiment tracks whether our life story is written in our gut bacteria

Provided by University of Cincinnati Academic Health Center

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Research uncovers new steps on pathway to enlarged heart

Oct 23, 2008

Researchers have new insight into the mechanisms that underlie a pathological increase in the size of the heart. The research, published by Cell Press in the October 24th issue of the journal Molecular Cell, may lead to the ...

Recommended for you

New technology allows hair to reflect almost any color

2 hours ago

What if you could alter your hair to reflect any color in the spectrum? What if you could use a flatiron to press a pattern into your new hair color? Those are possibilities suggested by researchers from ...

Monitoring the rise and fall of the microbiome

10 hours ago

Trillions of bacteria live in each person's digestive tract. Scientists believe that some of these bacteria help digest food and stave off harmful infections, but their role in human health is not well understood.

User comments : 0